Results 161 to 170 of about 353,545 (343)

Serum Inhibitors of Elastase, Trypsin, and Plasmin in Chronic Rheumatic Diseases [PDF]

, 1966
Wojciech Ardelt, S. Ksiȩżny, Izabella Niedźwiecka-Namysłowska, Andrei Z. Budzynski   +3 more
openalex   +1 more source

Membrane Fusion‐Inspired Nanomaterials: Emerging Strategies for Infectious Disease and Cancer Diagnostics

Advanced Healthcare Materials, EarlyView.
Membrane fusion‐inspired nanomaterials offer transformative potential in diagnostics by mimicking natural fusion processes to achieve highly sensitive and specific detection of disease biomarkers. This review highlights recent advancements in nanomaterial functionalization strategies, signal amplification systems, and stimuli‐responsive fusion designs,
Sojeong Lee, Khulan Nyamzaya, Jueun Han, Yejin Song, Jihee Lee, Jung Hyun Jo, Seungmin Bang, Eun‐Kyung Lim, Seungjoo Haam, Eunjung Kim   +9 more
wiley   +1 more source

A Prospective Cohort Study of Inter-Alpha-Trypsin Inhibitor Heavy Chain 4 as a Serologic Marker in Relation to Severity and Functional Outcome of Acute Intracerebral Hemorrhage. [PDF]

Neuropsychiatr Dis Treat, 2023
Shentu HS, Chen YH, Cheng ZY, Fu B, Fu YH, Zheng SF, Li C.   +6 more
europepmc   +1 more source

Trypsin Inhibitor from Bovine Pancreatic Juice

, 1966
Lewis Joel Greene, Meir Rigbi, D S Fackre   +2 more
openalex   +1 more source

Activation of Coagulase Clotting by Trypsin Inhibitor [PDF]

, 1969
D. S. Orth, A. W. Anderson, M. W. MONTGOMERY   +2 more
openalex   +1 more source

Nanobody‐Decorated Lipid Nanoparticles for Enhanced mRNA Delivery to Tumors In Vivo

Advanced Healthcare Materials, EarlyView.
This study presents a targeted mRNA‐LNP platform engineered with anti‐PSMA nanobodies for prostate cancer therapy. Using different in vivo models, the authors demonstrate selective uptake and mRNA delivery in PSMA+ cancer cells. However, while targeting is enhanced, mRNA delivery efficacy is limited by tissue penetration, tumor necrosis, and immune ...
Pol Escudé Martinez de Castilla, Vincenzo Verdi, Willemijn de Voogt, Mariona Estapé Sentí, Arnold C. Koekman, Julian Rietveld, Sven van Kempen, Qiangbing Yang, Juliette van Merris, Guido Jenster, Martin E. van Royen, Marcel H. Fens, Sander A. A. Kooijmans, Wytske M. van Weerden, Guillaume van Niel, Pieter Vader, Raymond M. Schiffelers   +16 more
wiley   +1 more source

Trypsin inhibitors in seeds and pods of Phaseolus vulgaris/coccineus: A comparative study of shaking and ultrasonic extraction methods

Electronic Journal of Biotechnology
Background: Different methods for the extraction of trypsin inhibitors in beans (Phaseolus spp.) were investigated. Two randomised complete laboratory experiments were performed, one on the seeds and one on the pods.
Hourieh Tavakoli Hasanaklou, Barbara Pipan, Vladimir Meglič, Nevena Nagl, Lovro Sinkovič   +4 more
doaj  

Effect of Urinary Trypsin Inhibitor (Ulinastatin) Therapy in COVID-19. [PDF]

Indian J Crit Care Med, 2022
Jain A, Kasliwal R, Jain SS, Jain R, Gupta D, Gupta P, Jain A, Tambi R, Panwar P, Meena M, Jain R.   +10 more
europepmc   +1 more source

The Structure of the Bovine Pancreatic Secretory Trypsin Inhibitor—Kazal's Inhibitor

, 1969
Lewis Joel Greene, Diana C. Bartelt
openalex   +1 more source

Engineered MSC Aggregates with E/N‐Cadherin and IL‐6 Preconditioning for the Treatment of Systemic Sclerosis

Advanced Healthcare Materials, EarlyView.
Engineered 3D‐Cad/IL6‐MSC, developed through synergistic hE/N‐cad‐Fc and IL‐6 preconditioning, show remarkable therapeutic potential for systemic sclerosis. These engineered MSC aggregates reduce pathogenic inflammatory cell infiltration and restore immune balance among CD4+ T‐cell populations, offering a promising approach to optimize MSC based ...
Yue Zhang, Mengyuan Qian, Yirui Shi, Jiaxu Cao, Min Xu, Xin Wen, Yunxia Yan, Sha Liu, Hongwei Chen, Shanshan Liu, Jun Yang, Lingyun Sun   +11 more
wiley   +1 more source